Use of G+MET reduces symptomatic hypoglycemia and dinnertime hyperglycemia compared with NPH+MET, otherwise both provided good control.

Glargine plus Lispro provided better control then NPH insulin with less nocturnal hypoglycemia.

There appears to be an association between use of sulfonylureas or insulin and an increased risk of cancer in patients with type 2 diabetes, compared with patients treated with metformin,

HemoCue Monitor for Home Use- Clinical Accuracy at Home

Dr Frank Varon, DDS has spent significant time working with diabetic dental patients and knows well the improvements that proper dental care can have on glucose control. His first feature for us Diabetes and the Dental Patient points out the oral conditions that affect diabetes and how we as medical …

JANUVIA is an investigational once-daily medicine with a novel mechanism of action for the treatment of type 2 diabetes.

If Viagra (sildenafil) doesn’t do the job, maybe all it needs is a kick start with Lipitor (atorvastatin).

If a new finding by Burnham Institute and UCSD scientists holds true, millions of diabetics could someday drastically reduce their dependence on drugs and perhaps even have a cure.

The FDA issued an approvable letter on weight management today for Acomplia (rimonabant), spelling out the steps Sanofi-aventis needs to take to win final approval for its much-heralded diet drug. They do not approve it for smoking-cessation

Encapsulating insulin producing cells in tiny seaweed bubbles and injecting them into people with type 1 diabetes could one day remove the need for daily insulin injections.